Pediatrics

A study shows Atropine 0.01% eye drops decreased myopia progression in children over the course of 1 year.

According to National Eye Institute researchers, the strategy may speed the delivery of therapeutic options relative to time it would take to develop gene therapies.

The Phase 1/2 Clinical Trial is for the treatment of retinitis pigmentosa and Leber congenital amaurosis.

Hurdles include limited space, handling thin sclera, choosing the right site.

While low-dose atropine eye drops are currently being used to slow myopia progression in several countries in Asia, researchers set out to determine if the medication could also the onset of myopia.

During a presentation at the EnVision Summit Ophthalmology 2023 at El Conquistador Resort in Puerto Rico, Elena Bitrian, MD, outlines the challenges that surgeons are confronted with surgically in pediatric eyes, including the limited working space and palpebral fissure, axial length, and avoidance of the thin sclera and shallow scleral pass.

The approval of aflibercept for preterm infants with retinopathy of prematurity (ROP) expands the treatment armamentarium for these patients, comments Prof Anat Loewenstein.

According to Regeneron, aflibercept injection is now approved to treat five retinal conditions caused by ocular angiogenesis.

Wills Eye Hospital’s annual Give Kids Sight Day provides access to eyecare for children.

Jefferson Doyle, MBBCh, MD, PhD, MHS, of the Wilmer Eye Institute at Johns Hopkins University School of Medicine, addresses myopic concerns, such as public health measures including time outdoors, as well as pharmacological approaches including the current atropine data that has been completed and ongoing studies.

The company is poised to roll out its eye-tracking amblyopia treatment to the U.S. market.

The American Academy of Ophthalmology has declared December as Safe Toys and Celebrations Month, highlighting how eye-safe toys can help avoid serious eye injuries.

Researchers found through DNA sequencing and confirmed in further testing that a genetic mutation in the THBS1 gene led to the development of severe childhood glaucoma. The discovery may improve disease screening and personalize treatments.

According to physicians, patients who do not undergo second procedure are more likely to develop glaucoma.

The case series included 12 eyes of children with refractory childhood glaucoma who needed trabeculectomy or implantation of a glaucoma drainage device.

According to the company, ROP Check builds upon its pediatric retina screening portfolio, adding digital management (schedule, document, bill, and transfer) for treating patients with retinopathy of prematurity.

Preliminary data from the three-year, international study demonstrate safety and efficacy of NVK002 as a potential treatment for the progression of myopia in children.

According to a study, health disparities impact the rates of pediatric ophthalmology visits.

The company noted that the pediatric exclusivity determination is based on data from two Phase 3 trials – BUTTERFLEYE and FIREFLEYE.

According to NEXGEL, the patch is expected be available for ophthalmologists to offer to their patients in the first half of 2023.

NovaSight’s CureSight is a digital device that proved in a pivotal study to be non-inferior to patching, according to the company.

Donny W. Suh, MD, finds his love for practicing pediatric ophthalmology grows stronger with each passing year. He offers two tips to fellow physicians and his residents and fellows for managing the stressors of daily practice and for getting a good night’s sleep. He also shares his journey in a book called “Catching A Star,” with all proceeds going to a medical mission program.

UCI team demonstrates the adult brain has the potential to partially recover from inherited blindness.

Novel glasses, designed for children with cranial dysotosis, help doctors provide functional eyewear for children in underserved communities, says Donny Suh, MD.

During a presentation at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago, Vivian Paraskevi Douglas, MD, DVM, MBA, MSc, detailed a study in which investigators used the extensive data in the American Academy of Ophthalmology IRIS Registry to study the difference between the pediatric and adult populations.